Home > JDM>

Prof. Franco Battista Ennio Folli

University of Texas, USA

Email: folli@uthscsa.edu


1996 Ph.D., Università di Milano e Padova, Italy

Publications (Selected)

  1. Chavez AO, Kamath S, Jani R, Sharma LK, Monroy A, Abdul-Ghani MA, Centonze VE, Sathyanarayana P, Coletta DK, Jenkinson CP, Bai Y, Folli F, Defronzo RA, Tripathy D. (2010). Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals. J Clin Endocrinol Metab. 95(1):422-429.
  2. Dall’Asta C, Vedani P, Manunta P, Pizzocri P, Marchi M, Paganelli M, Folli F, Pontiroli AE. (2009). Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity. Nutr Metab Cardiovasc Dis.19(2):110-4.
  3. Pontiroli A.E., Frige F., Paganelli M., Folli F. (2009) In morbid obesity, metabolic abnormalities and adhesion molecules correlate with visceral fat, not with subcutaneous fat: Effect of weight loss through surgery. Obes Surg. 19(6):745-50.
  4. Chavez AO, Gastaldelli A, Guardado-Mendoza R, Lopez Alvarenga JC, Leland MM, Tejero ME, Sorice G, Casiraghi F, Davalli AM, Bastarrachea RA, Comuzzie AG, DeFronzo RA, Folli F. (2009) Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons. Cardiovasc Diabetol.8:22.
  5. Chavez AO, Molina-Carrion M, Abdul-Ghani M, Folli F, DeFronzo RA, Tripathy D (2009). Circulating Fibroblast Growth Factor-21 (FGF-21) is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care. 32 (8):1542-1546.
  6. Monroy A, Kamath S, Chavez AO, Centonze VE, Veerasamy M, Barrentine A, Wewer JJ, Coletta DK, Jenkinson C, Jhingan RM, Smokler D, Reyna S, Musi N, Khokka R, Federici M, Tripathy D, DeFronzo RA, Folli F. (2009). Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans. Diabetologia. 52(10):2169-2181.
  7. Guardado-Mendoza R, Dick EJ, Jimenez-Ceja LM, Davalli A, Chavez AO, Folli F, Hubbard GB. Spontaneous pathology of the baboon endocrine system. J Med Primatol. 38(6):383-389.
  8. Guardado-Mendoza R, Davalli AM, Chavez AO, Hubbard GB, Dick EJ, Majluf-Cruz A, Tene-Perez CE, Perego C, Goldschmidt L, Hart J, Comuzzie AG, Tejero ME, Finzi G, Placidi C, La Rosa S, Capella C, Halff G, Gastaldelli A, DeFronzo RA, Folli F. (2009) Pancreatic Islet Amyloidosis, Beta Cell Apoptosis and Alpha Cell Proliferation are Determinants of Islet Remodeling in Type 2 diabetic baboons. Proc Natl Acad Sci USA. 106(33):13992-7.
  9. Dall'Asta C, Paganelli M, Morabito A, Vedani P, Barbieri M, Paolisso G, Folli F, Pontiroli AE (2009). Weight Loss through gastric banding: effect on TSH and thyroid hormones in obese subject with normal thyroid function. Obesity. (Silver Spring) Oct.2009.
  10. Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, Porzio O, Mauriello A, Solini A, Ippoliti A, Lauro R, Folli F, Federici M. (2009). TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by Sirt1. Diabetes. 58(10):2396-2401.
  11. Pontiroli AE, Laneri M, Veronelli A, Frige’ F, Micheletto G, Folli F, Adami G, Scopinaro N. (2009). Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and cardiovascular parameters. Cardiovasc Diabetol. 8(1):37.
  12. Frigé F, Laneri M, Veronelli A, Folli F, Paganelli M, Vedani P, Marchi M, Noé D, Ventura P, Opocher E, Pontiroli AE. (2008) Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis. 19(3):198-204.